君正集團(601216.SH):君正化工擬16.20億元公開出售華泰保險3.36%股份
格隆匯11月11日丨君正集團(601216.SH)公佈,公司全資子公司內蒙古君正化工有限責任公司(以下簡稱“君正化工”)擬通過公開徵集競買人和公開拍賣的方式將所持有的華泰保險集團股份有限公司1.35億股股份(佔總股份的3.3568%)進行出售,公開出售標的股權的底價為16.20億元,每股12元;公司全資子公司君正化工本次公開出售其持有的華泰保險部分股份,將優化公司資產結構,充裕公司營運資金,降低財務費用,支持公司向新興產業轉型升級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.